Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor
- Resource Type
- Article
- Source
- In
Vascular Pharmacology September 2020 132 - Subject
- Language
- ISSN
- 1537-1891